Literature DB >> 22429860

Treatment of corneal defects with delayed re-epithelization with a medical device/drug delivery system for epidermal growth factor.

Simon Holland1, Douglas Morck, Clyde Schultz.   

Abstract

BACKGROUND: Human recombinant epidermal growth factor has been shown to be effective in corneal healing when applied topically. The purpose of this preliminary study was to observe whether re-epithelization occurred in patients with non-healing corneal defects treated with a bandage contact lenses impregnated with epidermal growth factor.
DESIGN: Prospective non-comparative interventional case series study. Epidermal growth factor-impregnated bandage contact lenses (created through passive transfer of epidermal growth factor into hydrogel contact lenses of high water content) were used to passively release epidermal growth factor to the corneal surface of the damaged eye. PARTICIPANTS: Nine clinical patients who presented for tertiary care at the University of British Columbia Eye Care Centre at Vancouver General Hospital.
METHODS: All patients had clinically significant delayed corneal re-epithelization that had not healed despite standard treatments including conventional bandage contact lenses and topical medications. Causes of delayed re-epithelization varied from corneal injuries (e.g. alkali burns, recurrent corneal erosions) to recent corneal surgery (photorefractive keratectomy, phototherapeutic keratectomy, penetrating keratoplasty). MAIN OUTCOME MEASURES: Closure of wounds.
RESULTS: Re-epithelialization was seen in the corneas of seven of the nine patients within 8 days after insertion of the epidermal growth factor-treated bandage contact lens into the damaged eye. The drug delivery system appeared to be most effective in non-inflamed corneas.
CONCLUSIONS: Preliminary results indicate that bandage contact lenses impregnated with epidermal growth factor may be helpful in promoting re-epithelization in corneas with delayed healing. Efficacy appears to be reduced for vascularized and significantly inflamed corneas.
© 2012 The Authors. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429860     DOI: 10.1111/j.1442-9071.2012.02795.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

Review 1.  Review: corneal epithelial stem cells, their niche and wound healing.

Authors:  Federico Castro-Muñozledo
Journal:  Mol Vis       Date:  2013-07-24       Impact factor: 2.367

Review 2.  Therapeutic Ophthalmic Lenses: A Review.

Authors:  N Toffoletto; B Saramago; A P Serro
Journal:  Pharmaceutics       Date:  2020-12-28       Impact factor: 6.321

3.  The PACAP-derived peptide MPAPO facilitates corneal wound healing by promoting corneal epithelial cell proliferation and trigeminal ganglion cell axon regeneration.

Authors:  Zixian Wang; Wailan Shan; Huixian Li; Jia Feng; Shiyin Lu; Biqian Ou; Min Ma; Yi Ma
Journal:  Int J Biol Sci       Date:  2019-10-15       Impact factor: 6.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.